NCT03600961View on ClinicalTrials.gov

BIOFLOW-SV Portugal Registry

TerminatedOBSERVATIONAL
Enrollment

173

Participants

Timeline

Start Date

July 5, 2018

Primary Completion Date

December 30, 2020

Study Completion Date

December 21, 2021

Conditions
Ischemic Heart Disease
Interventions
DEVICE

Orsiro Sirolimus Eluting Coronary Stent System

Percutaneous coronary intervention

Trial Locations (4)

2799-134

Hospital de Santa Cruz, Carnaxide

Unknown

Hospital da Luz, Carnaxide

Hospital Espirito Santo Evora, Evora

2410-197

Centro Hospitaler de Leiria E.P.E., Leiria

Sponsors

Lead Sponsor

Biotronik AG
All Listed Sponsors
lead

Biotronik AG

INDUSTRY